홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RLAY
#1753
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+14.77%
월간 변동
+21.42%
6달 변화
+185.79%
년간 변동율
+213.76%
이전 종가
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
양
219
마켓
주식
헬스케어
RLAY
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
167.38 M
169.52 M
171.44 M
172.41 M
173.32 M
178.73 M
—
Valuation ratios
Enterprise value
1.03 B
574.14 M
355.64 M
482.6 M
813.18 M
1.43 B
3.08 B
Price to earnings ratio
-2.72
-1.75
-1.19
-1.8
-3.03
-5.25
-11.28
Price to sales ratio
92.58
58.82
57.74
70.14
105.82
—
—
Price to cash flow ratio
3.3
2.36
1.4
2.04
3.43
6.17
13.04
Price to book ratio
0.31
0.76
0.13
0.18
0.3
2.56
3.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.09
0.09
0.1
0.1
0.11
0.09
0.39
Return on equity %
0.11
0.1
0.11
0.11
0.12
0.1
0.43
Return on invested capital %
—
—
—
—
—
1 036.09
—
Gross margin %
—
—
100
100
—
100
—
Operating margin %
—
—
1 105.21
11.35 K
—
866.28
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
1 003.58
10.4 K
—
784.25
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
18.42
15.95
19.96
20.92
19.14
22.61
82.63
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0.01
0
0
0.01
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.54
0.41
0.43
0.32
0.36
0.26
1.38
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1.09
0.87
0.55
0.67
0.53
0.49
2.24
Net current asset value per share
6.17
5.66
4.37
3.97
3.62
3.37
15.33
Tangible book value per share
5.97
5.43
4.25
3.89
3.53
3.3
14.96
Working capital per share
5.83
5.31
4.15
3.78
3.43
3.22
14.59
Book value per share
5.98
5.44
4.26
3.89
3.53
3.3
14.98
뉴스
Relay Therapeutics stock hits 52-week high at 9.64 USD
릴레이 테라퓨틱스 Q4 실적, 수익 예상치를 넘어
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
릴레이 테라퓨틱스, FDA 혁신 치료제 지정 후 실적 주목
Relay Therapeutics earnings in spotlight after FDA breakthrough
BB Biotech 2025 회계연도: 660% 이익 급증, 2026년 전망은 신중
Relay earnings in focus as FDA breakthrough fuels optimism
릴레이 테라퓨틱스, FDA 혁신 치료제 지정 후 주가 상승
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status
릴레이 테라퓨틱스 유방암 치료제, FDA 혁신 치료제 지정
FDA grants breakthrough therapy status to Relay’s breast cancer drug